About | Free Trial

Last Update

2016-06-05T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong James Armitage?

Dr. James Armitage O.

Joe Shapiro Professor of Medicine

University of Nebraska Medical Center

Direct Phone: (402) ***-****       

Email: j***@***.edu

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of Nebraska Medical Center

982055 Nebraska Medical Center

Omaha, Nebraska 68198

United States

Company Description

About University of Nebraska Medical Center:UNMC, with its clinical partner, Nebraska Medicine, is a leading academic medical center, perhaps best known for its treatment, at the request of the U.S. State Department, of three Ebola patients. It also is a ... more

Find other employees at this company (3,947)

Background Information

Employment History

Bone Marrow Transplant Program

University of Iowa

President

American Society of Clinical Oncology

President

American Society for Blood and Marrow Transplantation

Affiliations

Fellow
American Association for the Advancement of Science

Medical Advisory Board Member
Oncology Consortium

Board Member
Lymphoma and Myeloma Oncology Consortium

Board Member
TESARO, Inc.

U.S. Medical Advisory Board Member
Patient Resource LLC

Board Member
ZIOPHARM Oncology , Inc.

Board Member
Spectrum

U.S. Medical Advisory Board Member
Patient Resource Publishing LLC

Fellow
Royal College of Physicians

Myeloid Growth Factors Panel Member
National Comprehensive Cancer Network Inc

SCIENTIFIC ADVISORY BOARD Member
Imedex LLC

Member
American Society of Hematology

Member
American Association for Cancer Research Inc

Fellow
Cancer Progress

Many National and International Oncology Committees
the United States National Cancer Advisory Board and the French National Cancer Advisory Board

Scientific Committee
International Congress on Anti-Cancer Treatment

Member, Many National and International Boards
Einstein-Montefiore Center for Continuing Medical Education

Member, Academic Advisory Board
Oncology Analytics Inc

Scientific Advisory Board Member
Hana Biosciences , Inc.

Education

UNMC College of Medicine

leadership roles

University of Nebraska Medical Center

B.S. degree

University of Nebraska , Lincoln

M.D.

M.D.

The University of Nebraska College of Medicine

M.D.

University of Nebraska College of Medicine , Omaha

M.D.

University of Nebraska Medical Center

M.D.

Winship Cancer Institute

M.D. degree

University of Nebraska , Omaha

MD

The John Hopkins University School of Medicine

MD

The University of Texas M.D.

MD

University of Nebraska

MD

University of Pennsylvania Health System

bachelor of science degree

University of Nebraska at Lincoln

medical degree

University of Nebraska College of Medicine

medical degree

University of Nebraska Medical Center

Web References (199 Total References)


Leukemia, Lymphoma, and Myeloma Oncology Consortium | Oncology Consortium

theoncologyconsortium.com [cached]

James O. Armitage, MD

...
Dr. James O. Armitage, a graduate of the University of Nebraska Medical Center, completed his internship and residency in Internal Medicine at Nebraska, a fellowship in Hematology/Oncology at the University of Iowa and a brief stint in private practice in Omaha. He developed and directed the Bone Marrow Transplant program at the University of Iowa and later at the University of Nebraska. At Nebraska he served as Vice-Chair of Internal Medicine, Chief of the Section of Oncology and Hematology, Chair of the Department of Internal Medicine, and Dean of the College of Medicine. He currently is The Joe Shapiro Professor of Medicine at the University of Nebraska Medical Center. Dr. Armitage is board certified in Internal Medicine, Medical Oncology, and Hematology, and a Fellow of both the American and Royal College of Physicians and of the American Association for the Advancement of Sciences. He has served on many national/international oncology committees including the United States National Cancer Advisory Board and the French National Cancer Advisory Board. He is past president of both the American Society of Clinical Oncology and the American Society of Blood and Marrow Transplantation. He has served on the Scientific Committee of the International Congress on Anti-Cancer Treatment in Paris, France, the International Symposium on Hodgkin Lymphoma in Cologne, Germany and the International Conference on Malignant Lymphoma in Lugano, Switzerland.


.:: Patient Resource Publishing : The Advisory Board ::.

www.patientresource.com [cached]

James O. Armitage, MD

Professor, Internal Medicine
...
Dr. James O. Armitage is a graduate of the University of Nebraska Medical Center, completed his internship and residency in internal medicine at Nebraska, a fellowship in hematology oncology at the University of Iowa and a brief stint in private practice in Omaha. He developed and directed the Bone Marrow Transplant program at the University of Iowa and later at the University of Nebraska. He served as Vice-Chair of Internal Medicine, Chair of Internal Medicine, Dean of the College of Medicine and currently is The Joe Shapiro Professor of Medicine at the University of Nebraska Medical Center. Dr. Armitage is board certified in internal medicine, medical oncology and hematology, a Fellow of both the American and Royal College of Physicians, a past member of the National Cancer Advisory Board, past president of the American Society of Clinical Oncology and American Society of Blood and Marrow Transplantation. He is married and the father of four children and four grandchildren.


How I treat DLBC - A ...

www.nhlcyberfamily.org [cached]

How I treat DLBC - A discussion by Dr. James Armitage The Joe Shapiro Professor of Medicine, University of Nebraska Medical Center, Omaha


Charles L. Bennett, MD, PhD, MPP ...

www.ascopost.com [cached]

Charles L. Bennett, MD, PhD, MPP and James O. Armitage, MD / 2015 ASCO Annual Meeting

...
Charles L. Bennett, MD, PhD, MPP, and James O. Armitage, MD, on Biosimilars in Oncology
...
Charles L. Bennett, MD, PhD, MPP of the University of South Carolina College of Pharmacy, and James O. Armitage, MD, of the University of Nebraska Medical Center, discuss the emerging and future benefits of biosimilars.


James O. Armitage, MD, FACP, ...

www.ascopost.com [cached]

James O. Armitage, MD, FACP, FRCP, and Richard M. Stone, MD / 2014 ASH Annual Meeting

...
James O. Armitage, MD, FACP, FRCP, and Richard M. Stone, MD, on Clinical Trial Results for AML, MDS, and CMML Treatment
...
James O. Armitage, MD, FACP, FRCP, of the University of Nebraska Medical Center, and Richard M. Stone, MD of the Dana-Farber Cancer Institute, discuss three clinical trials: different doses of daunorubicin for AML; comparing azacitidine plus lenolidomide to vorinostat vs azacitidine monotherapy in MDS and CMML; and sorafenib vs placebo in addition to standard treatment for AML.
...
James O. Armitage, MD, FACP, FRCP, and Richard M. Stone, MD / 2014 ASH Annual Meeting
...
James O. Armitage, MD, FACP, FRCP, and Richard M. Stone, MD, on Progress Made Against AML and APL
...
James.
...
James O. Armitage, MD, FACP, FRCP, and Hagop M. Kantarjian, MD / 2014 ASH Annual Meeting
...
James O. Armitage, MD, FACP, FRCP, and Hagop M. Kantarjian, MD, on Advances in the Treatment of ALL
...
James O. Armitage, MD, FACP, FRCP, of the University of Nebraska Medical Center, and Hagop M. Kantarjian, MD, of The University of Texas MD Anderson Cancer Center, discuss the diagnosis and genetics of ALL, differences in treating younger and older patients, and the latest data on the use of tyrosine kinase inhibitors, monoclonal antibodies, and CAR T cells.
...
Asher Alban Chanan-Khan, MD, and James O. Armitage, MD / 2015 ASCO Annual Meeting
...
Asher Alban Chanan-Khan, MD, and James O. Armitage, MD, on Ibrutinib, Bendamustine, and Rituximab in Previously Treated CLL/SLL
...
James O. Armitage, MD, of the University of Nebraska Medical Center, and Asher Alban Akmal Chanan-Khan, MD, of the Mayo Clinic Cancer Center, discuss an important treatment option that significantly improved overall response rate and reduced risk of progression or death by 80% (Abstract LBA7005).

Similar Profiles

Other People with this Name

Other people with the name Armitage

Paul Armitage
Gane International Ltd

Gemma Armitage
Physio Med Limited

Michelle Armitage

Karl Armitage
Gane International Ltd

Steve Armitage
UD Group

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory